Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded NIH grant/contract attribution for 2016 and updated the documentation revision to v3.6.6, reflecting a minor metadata update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5. This is a metadata version refresh that does not reflect changes to substantive content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. This is a metadata update and does not alter the study details or how users interact with the record.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a small update to the study record.SummaryDifference0.0%

- Check76 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer release of the study page. This internal update does not alter the study details, eligibility criteria, or results.SummaryDifference0.0%

- Check91 days agoChange DetectedRecruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). A formatting tweak changes 'Intervention / Treatment' to 'Intervention/Treatment' and the revision label updated to Revision: v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.